Edition:
United Kingdom

Ovid Therapeutics Inc (OVID.OQ)

OVID.OQ on NASDAQ Stock Exchange Global Select Market

3.19USD
11 Dec 2018
Change (% chg)

-- (--)
Prev Close
$3.19
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
14,953
52-wk High
$12.19
52-wk Low
$3.10

Chart for

About

Ovid Therapeutics Inc. (Ovid) is a biopharmaceutical company. The Company is engaged in developing medicines for patients and families living with rare neurological disorders. Its lead drug candidate is OV101. The Company’s second lead drug candidate is OV935. OV101 (gaboxadol) is a delta-selective GABAA receptor agonist. Ovid... (more)

Overall

Beta: --
Market Cap(Mil.): $206.16
Shares Outstanding(Mil.): 24.60
Dividend: --
Yield (%): --

Financials

  OVID.OQ Industry Sector
P/E (TTM): -- 92.25 33.63
EPS (TTM): -- -- --
ROI: -- 0.29 15.02
ROE: -- 0.94 16.60

Earnings vs. Estimates